行情

CSBR

CSBR

Champions
NASDAQ

实时行情|Nasdaq Last Sale

7.39
+0.21
+2.92%
休市 16:00 04/09 EDT
开盘
7.20
昨收
7.18
最高
7.50
最低
7.12
成交量
3.37万
成交额
--
52周最高
10.44
52周最低
4.020
市值
8,784.97万
市盈率(TTM)
-313.1356
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测CSBR价格均价为10.33,最高价位12.00,最低价为8.00。

EPS

CSBR 新闻

更多
  • 白俄罗斯总理建议欧亚经济联盟大力推动去美元化进程
  • 央视 · 1小时前
  • 摩根大通大幅下调对美国经济前景的预期
  • 新浪财经综合 · 1小时前
  • 2.3万亿美元并非最后一搏,美联储还能继续放水!
  • 新浪财经综合 · 1小时前
  • 美股战“疫”小记:美股在这个早春都经历了什么?
  • 新浪财经综合 · 1小时前

所属板块

生物技术和医学研究
+1.63%
制药与医学研究
+0.82%

热门股票

代码
价格
涨跌幅

CSBR 简况

Champions Oncology, Inc. is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company has two business segments: Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). The POS segment provides physicians and patients information to help guide the development of personalized treatment plans. The TOS segment provides services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. Its TumorGraft Technology Platform consists of processes, physical tumors and information that it uses to personalize the development and use of oncology drugs. Each tumor from patients that it has preserved for implantation in mice, along with the patient data and molecular information associated with the tumors, are known as TumorGrafts or Patient Derived XenoGrafts of PDX Models. The collection of TumorGrafts is referred to as the Company's TumorBank.
展开

微牛提供Champions Oncology Inc(NASDAQ-CSBR)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的CSBR股票新闻,以帮助您做出投资决策。